查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1566949

血管隔離醫用黏劑市場：按程序、最終用戶：2024-2033 年全球機會分析與產業預測

Vascular Sealing Medical Glue Market By Procedure (Revascularization, Others) , By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers) : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023年，血管密封劑醫用黏劑市場估值為7億美元，預計2024年至2033年複合年成長率為7.3%，到2033年達到14億美元。

血管黏劑是一種具有高黏合性和止血性能的外科黏劑，用於組織封閉和加固。這些黏劑在受傷組織之間以及組織與植入生物材料之間建立功能連接方面發揮著至關重要的作用。開發這種黏劑是為了最大限度地減少對傳統手術中有用的手術縫合和機械組織融合方法的需求。這是因為與傳統方法相比，血管密封黏劑可促進組織再生和癒合，降低感染風險，並最大限度地減少組織創傷。市面上的天然醫用黏劑包括纖維蛋白黏劑和膠原蛋白產品，它們具有很高的黏合效果。

全球血管閉塞醫用黏劑市場的成長是由心血管疾病盛行率的驚人上升以及血管成形術和冠狀動脈繞道手術術等手術需求的相應增加所推動的，這是推動醫用黏劑需求的主要因素。根據世界心臟聯盟的數據，心血管疾病是全球第一大死因，超過其他原因。每年約有 2050 萬人死於心血管疾病。其中，85%是由於冠狀動脈疾病（如心臟病）和腦血管疾病（如中風）引起的。此外，老年人口的增加對市場成長做出了重大貢獻。這是因為老年人更容易患心臟疾病，並且經常需要手術來解決靜脈曲張和動脈硬化等問題，這增加了對醫用黏劑來密封血管的需求。根據西班牙心臟學會官方刊物Revista Espanola de Cardiologia發表的論文，心臟疾病是81% 65歲以上成年人的主要死因。此外，由於更快的恢復時間和更短的住院時間，患者和醫療保健提供者對微創手術的偏好日益增加，也推動了市場的成長。然而，與血管閉合用醫用黏劑相關的安全問題正在阻礙市場成長。例如，一些黏劑具有細胞毒性且吸收性差，這限制了它們在醫療保健環境中的需求。此外，醫用黏劑無法提供充分且即時的密封、感染風險增加以及癒合延遲也是市場的主要阻礙因素。相反，為了降低手術部位感染的風險，製造商正在開發具有抗菌特性的用於血管閉合的醫用黏劑，以確保術後護理和患者安全。此外，醫用黏劑配方中不斷的技術創新以增強黏合強度預計將為預測期內的市場擴張提供利潤豐厚的機會。

全球血管密封劑醫用黏劑市場按程序、最終用戶和地區細分。依程序，市場分為重組和其他。依最終使用者分為醫院、專科診所和門診手術中心。按地區分類，對北美、歐洲、亞太地區和拉丁美洲地區市場進行了分析。

主要發現

  • 從手術方式來看，重組在 2023 年佔據了市場佔有率。
  • 按最終用戶分類，醫院領域在 2023 年呈現最高成長。
  • 按地區分類，北美將在 2023 年引領市場，而亞太地區預計在預測期內複合年成長率最高。

可以自訂此報告（需要額外的成本和時間表）。

  • 監管指引
  • 根據客戶興趣加入公司簡介
  • 按國家或地區進行的附加分析 – 市場規模和預測
  • 公司簡介的擴充列表
  • 歷史市場資料
  • 主要參與者的詳細資料（Excel格式，包括位置、聯絡資訊、供應商/供應商網路等）

目錄

第1章簡介

第 2 章執行摘要

第3章 市場狀況

  • 市場定義和範圍
  • 主要發現
    • 主要投資機會
    • 關鍵成功策略
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會

第4章血管隔離醫用黏劑市場：依程序

  • 市場概況
  • 重組
  • 其他

第5章血管隔離醫用黏劑市場：依最終用戶分類

  • 市場概況
  • 醫院
  • 專科診所
  • 門診手術中心

第6章血管隔離醫用黏劑市場：按地區

  • 市場概況
  • 北美洲
    • 主要市場趨勢和機遇
    • 美國血管閉合用醫用黏劑市場
    • 加拿大血管密封醫用黏劑市場
    • 墨西哥血管閉合醫用黏劑市場
  • 歐洲
    • 主要市場趨勢和機遇
    • 德國血管封閉醫用黏劑市場
    • 法國血管封閉醫用黏劑市場
    • 英國血管閉合醫用黏劑市場
    • 義大利血管封閉醫用黏劑市場
    • 西班牙血管閉合醫用黏劑市場
    • 其他歐洲國家血管閉合醫用黏劑市場
  • 亞太地區
    • 主要市場趨勢和機遇
    • 日本血管閉合用醫用黏劑市場
    • 中國血管閉合醫用黏劑市場
    • 澳洲血管封閉醫用黏劑市場
    • 印度血管密封醫用黏劑市場
    • 韓國血管閉合用醫用黏劑市場
    • 其他亞太血管閉塞醫用黏劑市場
  • 拉丁美洲/中東/非洲
    • 主要市場趨勢和機遇
    • 巴西血管封閉醫用黏劑市場
    • 沙烏地阿拉伯血管隔離醫用黏劑市場
    • 南非血管閉合醫用黏劑市場
    • 其他拉丁美洲/中東/非洲血管閉合用醫用黏劑市場

第7章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 主要企業定位（2023年）

第8章 公司簡介

  • Baxter International Inc.
  • Becton, Dickinson And Company
  • Artivion, Inc.
  • Success Bio-tech
  • Integra LifeSciences Holdings Corporation
  • Stryker Corporation
  • Abbott Laboratories
  • Terumo Corporation
  • Johnson And Johnson
  • Medtronic
簡介目錄
Product Code: A324057

The vascular sealing medical glue market was valued at $0.7 billion in 2023, and is projected to reach $1.4 billion by 2033, growing at a CAGR of 7.3% from 2024 to 2033.

Vascular sealing medical glue is a surgical adhesive that possesses high adhesive and hemostatic properties, and is used to seal and reinforce tissues. These adhesives are play a pivotal role in creating functional connections between damaged tissues and between tissues and implanted biomaterials. They are majorly developed to minimize the use of surgical sutures and mechanical methods of tissue fusion, which are useful in conventional surgeries. This is attributed to the fact that vascular sealing glues promote tissue regeneration and healing, mitigate the risk of infection, and minimize tissue trauma as compared to conventional methods. Natural medical adhesives available in the market include fibrin adhesives and collagen-based products, which are highly effective in adhesion.

The growth of the global vascular sealing medical glue market is majorly driven by alarming rise in prevalence of cardiovascular diseases and corresponding increase in need for surgeries, such as angioplasty and coronary artery bypass grafting, are boosting the demand for vascular sealing medical glue. According to the World Heart Federation, cardiovascular diseases are the leading cause of death worldwide as compared to any other cause. Approximately 20.5 million die every year due to cardiovascular diseases. Of these deaths, 85% are due to coronary heart diseases (e.g., heart attacks) and cerebrovascular diseases (e.g., strokes). Moreover, increase in geriatric population significantly contributes toward the growth of the market. This is attributed to the fact that aged individuals are highly susceptible to cardiac diseases and often require procedures to address issues such as varicose veins and atherosclerosis, thus increasing the need for vascular sealing glues. As per the article published by the Revista Espanola de Cardiologia-the official publication of the Spanish Society of Cardiology-coronary heart disease is the leading cause of death in 81% of adults aged 65 years or older. Furthermore, increase in preference for minimally invasive procedures among patients and healthcare providers due to quicker recovery times and reduced hospital stays fosters the growth of the market. However, safety concerns associated with vascular sealing medical glue hamper the growth of the market. For instance, some adhesives are cytotoxic and are poorly absorbed, which limit their demand in healthcare settings. Furthermore, inability to medical adhesives to provide adequate and immediate seal, increased risk of infection, and delayed healing act as the key deterrent factors of the market. On the contrary, to reduce the risk of infection at the surgical sites, manufacturers are developing vascular sealing medical glue with antimicrobial properties, thus ensuring post-operative care and patient safety. In addition, continuous innovations in the formulation of medical glues to enhance their adhesive strength are expected to offer lucrative opportunities for the expansion of the market during the forecast period.

The global vascular sealing medical glue market is segmented into procedure, end user, and region. By procedure, the market is categorized into revascularization and others. On the basis of end user, it is divided into hospitals, specialty clinics, and ambulatory surgical centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

  • By procedure, the revascularization segment dominated the market share in 2023.
  • On the basis of end user, the hospitals segment exhibited the highest growth in 2023.
  • Region wise, North America lead the market in 2023; however, Asia-Pacific is expected to register highest CAGR during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global vascular sealing medical glue market include Baxter International Inc., Becton, Dickinson and Company, Artivion, Inc., Success Bio-tech, Integra LifeSciences Holdings Corporation, Stryker Corporation, Abbott Laboratories, Terumo Corporation, Johnson & Johnson, and Medtronic. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Procedure

  • Revascularization
  • Others

By End User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Baxter International Inc.
    • Becton, Dickinson and Company
    • Artivion, Inc.
    • Success Bio-tech
    • Integra LifeSciences Holdings Corporation
    • Stryker Corporation
    • Abbott Laboratories
    • Terumo Corporation
    • Johnson & Johnson
    • Medtronic

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Procedure
  • 4.2. Revascularization
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Others
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By End User
  • 5.2. Hospitals
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Specialty Clinics
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Ambulatory Surgical Centers
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: VASCULAR SEALING MEDICAL GLUE MARKET, BY REGION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Region
  • 6.2. North America
    • 6.2.1. Key Market Trends and Opportunities
    • 6.2.2. Market Size and Forecast, By Procedure
    • 6.2.3. Market Size and Forecast, By End User
    • 6.2.4. Market Size and Forecast, By Country
    • 6.2.5. U.S. Vascular Sealing Medical Glue Market
      • 6.2.5.1. Market Size and Forecast, By Procedure
      • 6.2.5.2. Market Size and Forecast, By End User
    • 6.2.6. Canada Vascular Sealing Medical Glue Market
      • 6.2.6.1. Market Size and Forecast, By Procedure
      • 6.2.6.2. Market Size and Forecast, By End User
    • 6.2.7. Mexico Vascular Sealing Medical Glue Market
      • 6.2.7.1. Market Size and Forecast, By Procedure
      • 6.2.7.2. Market Size and Forecast, By End User
  • 6.3. Europe
    • 6.3.1. Key Market Trends and Opportunities
    • 6.3.2. Market Size and Forecast, By Procedure
    • 6.3.3. Market Size and Forecast, By End User
    • 6.3.4. Market Size and Forecast, By Country
    • 6.3.5. Germany Vascular Sealing Medical Glue Market
      • 6.3.5.1. Market Size and Forecast, By Procedure
      • 6.3.5.2. Market Size and Forecast, By End User
    • 6.3.6. France Vascular Sealing Medical Glue Market
      • 6.3.6.1. Market Size and Forecast, By Procedure
      • 6.3.6.2. Market Size and Forecast, By End User
    • 6.3.7. UK Vascular Sealing Medical Glue Market
      • 6.3.7.1. Market Size and Forecast, By Procedure
      • 6.3.7.2. Market Size and Forecast, By End User
    • 6.3.8. Italy Vascular Sealing Medical Glue Market
      • 6.3.8.1. Market Size and Forecast, By Procedure
      • 6.3.8.2. Market Size and Forecast, By End User
    • 6.3.9. Spain Vascular Sealing Medical Glue Market
      • 6.3.9.1. Market Size and Forecast, By Procedure
      • 6.3.9.2. Market Size and Forecast, By End User
    • 6.3.10. Rest of Europe Vascular Sealing Medical Glue Market
      • 6.3.10.1. Market Size and Forecast, By Procedure
      • 6.3.10.2. Market Size and Forecast, By End User
  • 6.4. Asia-Pacific
    • 6.4.1. Key Market Trends and Opportunities
    • 6.4.2. Market Size and Forecast, By Procedure
    • 6.4.3. Market Size and Forecast, By End User
    • 6.4.4. Market Size and Forecast, By Country
    • 6.4.5. Japan Vascular Sealing Medical Glue Market
      • 6.4.5.1. Market Size and Forecast, By Procedure
      • 6.4.5.2. Market Size and Forecast, By End User
    • 6.4.6. China Vascular Sealing Medical Glue Market
      • 6.4.6.1. Market Size and Forecast, By Procedure
      • 6.4.6.2. Market Size and Forecast, By End User
    • 6.4.7. Australia Vascular Sealing Medical Glue Market
      • 6.4.7.1. Market Size and Forecast, By Procedure
      • 6.4.7.2. Market Size and Forecast, By End User
    • 6.4.8. India Vascular Sealing Medical Glue Market
      • 6.4.8.1. Market Size and Forecast, By Procedure
      • 6.4.8.2. Market Size and Forecast, By End User
    • 6.4.9. South Korea Vascular Sealing Medical Glue Market
      • 6.4.9.1. Market Size and Forecast, By Procedure
      • 6.4.9.2. Market Size and Forecast, By End User
    • 6.4.10. Rest of Asia-Pacific Vascular Sealing Medical Glue Market
      • 6.4.10.1. Market Size and Forecast, By Procedure
      • 6.4.10.2. Market Size and Forecast, By End User
  • 6.5. LAMEA
    • 6.5.1. Key Market Trends and Opportunities
    • 6.5.2. Market Size and Forecast, By Procedure
    • 6.5.3. Market Size and Forecast, By End User
    • 6.5.4. Market Size and Forecast, By Country
    • 6.5.5. Brazil Vascular Sealing Medical Glue Market
      • 6.5.5.1. Market Size and Forecast, By Procedure
      • 6.5.5.2. Market Size and Forecast, By End User
    • 6.5.6. Saudi Arabia Vascular Sealing Medical Glue Market
      • 6.5.6.1. Market Size and Forecast, By Procedure
      • 6.5.6.2. Market Size and Forecast, By End User
    • 6.5.7. South Africa Vascular Sealing Medical Glue Market
      • 6.5.7.1. Market Size and Forecast, By Procedure
      • 6.5.7.2. Market Size and Forecast, By End User
    • 6.5.8. Rest of LAMEA Vascular Sealing Medical Glue Market
      • 6.5.8.1. Market Size and Forecast, By Procedure
      • 6.5.8.2. Market Size and Forecast, By End User

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top Winning Strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

  • 8.1. Baxter International Inc.
    • 8.1.1. Company Overview
    • 8.1.2. Key Executives
    • 8.1.3. Company Snapshot
    • 8.1.4. Operating Business Segments
    • 8.1.5. Product Portfolio
    • 8.1.6. Business Performance
    • 8.1.7. Key Strategic Moves and Developments
  • 8.2. Becton, Dickinson And Company
    • 8.2.1. Company Overview
    • 8.2.2. Key Executives
    • 8.2.3. Company Snapshot
    • 8.2.4. Operating Business Segments
    • 8.2.5. Product Portfolio
    • 8.2.6. Business Performance
    • 8.2.7. Key Strategic Moves and Developments
  • 8.3. Artivion, Inc.
    • 8.3.1. Company Overview
    • 8.3.2. Key Executives
    • 8.3.3. Company Snapshot
    • 8.3.4. Operating Business Segments
    • 8.3.5. Product Portfolio
    • 8.3.6. Business Performance
    • 8.3.7. Key Strategic Moves and Developments
  • 8.4. Success Bio-tech
    • 8.4.1. Company Overview
    • 8.4.2. Key Executives
    • 8.4.3. Company Snapshot
    • 8.4.4. Operating Business Segments
    • 8.4.5. Product Portfolio
    • 8.4.6. Business Performance
    • 8.4.7. Key Strategic Moves and Developments
  • 8.5. Integra LifeSciences Holdings Corporation
    • 8.5.1. Company Overview
    • 8.5.2. Key Executives
    • 8.5.3. Company Snapshot
    • 8.5.4. Operating Business Segments
    • 8.5.5. Product Portfolio
    • 8.5.6. Business Performance
    • 8.5.7. Key Strategic Moves and Developments
  • 8.6. Stryker Corporation
    • 8.6.1. Company Overview
    • 8.6.2. Key Executives
    • 8.6.3. Company Snapshot
    • 8.6.4. Operating Business Segments
    • 8.6.5. Product Portfolio
    • 8.6.6. Business Performance
    • 8.6.7. Key Strategic Moves and Developments
  • 8.7. Abbott Laboratories
    • 8.7.1. Company Overview
    • 8.7.2. Key Executives
    • 8.7.3. Company Snapshot
    • 8.7.4. Operating Business Segments
    • 8.7.5. Product Portfolio
    • 8.7.6. Business Performance
    • 8.7.7. Key Strategic Moves and Developments
  • 8.8. Terumo Corporation
    • 8.8.1. Company Overview
    • 8.8.2. Key Executives
    • 8.8.3. Company Snapshot
    • 8.8.4. Operating Business Segments
    • 8.8.5. Product Portfolio
    • 8.8.6. Business Performance
    • 8.8.7. Key Strategic Moves and Developments
  • 8.9. Johnson And Johnson
    • 8.9.1. Company Overview
    • 8.9.2. Key Executives
    • 8.9.3. Company Snapshot
    • 8.9.4. Operating Business Segments
    • 8.9.5. Product Portfolio
    • 8.9.6. Business Performance
    • 8.9.7. Key Strategic Moves and Developments
  • 8.10. Medtronic
    • 8.10.1. Company Overview
    • 8.10.2. Key Executives
    • 8.10.3. Company Snapshot
    • 8.10.4. Operating Business Segments
    • 8.10.5. Product Portfolio
    • 8.10.6. Business Performance
    • 8.10.7. Key Strategic Moves and Developments